Join
Live feed
·
PRReleasevia Quantisnow
Jaguar Health Inc. logo

Dog Study Published in PLOS ONE Shows Statistically Significant Results for Use of Jaguar Health's Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea (CTD)

ByQuantisnow·Wall Street's wire, on your screen.
JAGX· Jaguar Health Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JAGX (Jaguar Health Inc.) and more on Quantisnow.